Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-15006841Phase 4Recruiting
Phase 4, open-label trial of propofol and sevoflurane in liver cancer (3 arms), sponsored by Eastern Hepatobiliary Surgery Hospital. Primary endpoint: Number of immune cells. Started Aug 2015; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-15006841.